Evidence map›Paper›PMID 25202424›Full record

ArticleOncology letters2014

Curcumin inhibits vasculogenic mimicry through the downregulation of erythropoietin-producing hepatocellular carcinoma-A2, phosphoinositide 3-kinase and matrix metalloproteinase-2.

Yiming Liang, Min Huang, Jianwen Li, Xinlin Sun, Xiaodan Jiang, Liangping Li, Yiquan Ke

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Curcumin Inhibits Vasculogenic MimicryCurrent cancer drug targets · 2024
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Yiming LiangDepartment of Neurosurgery, Guangzhou Red Cross Hospital, The Fourth Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510200, P.R. China ; Department of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China ; Institute of Neurosurgery, Key Laboratory on Brain Function Repair and Regeneration of Guangdong, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China.
Min HuangDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China ; Institute of Neurosurgery, Key Laboratory on Brain Function Repair and Regeneration of Guangdong, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China.
Jianwen LiNeurosurgery Department of Jiangmen Central Hospital, Jiangmen, Guangdong 529030, P.R. China.
Xinlin SunDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China ; Institute of Neurosurgery, Key Laboratory on Brain Function Repair and Regeneration of Guangdong, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China.
Xiaodan JiangDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China ; Institute of Neurosurgery, Key Laboratory on Brain Function Repair and Regeneration of Guangdong, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China.
Liangping LiDepartment of Neurosurgery, Guangzhou Red Cross Hospital, The Fourth Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510200, P.R. China.
Yiquan KeDepartment of Neurosurgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China ; Institute of Neurosurgery, Key Laboratory on Brain Function Repair and Regeneration of Guangdong, Southern Medical University, Guangzhou, Guangdong 510200, P.R. China.
Zhujiang Hospital · CNJinan University · CNJiangmen Central Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastomas (GBMs) are the most common and aggressive malignant primary brain tumors found in humans. In high-grade gliomas, vasculogenic mimicry (VM) is often detected. VM is the formation of

Indexed as

curcuminerythropoietin-producing hepatocellular carcinoma-A2gliomamatrix metalloproteinase-2phosphoinositide 3-kinasevasculogenic mimicry

Identifiers

PMID25202424
PMCPMC4156232
OpenAlexW2074399602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.